2015
DOI: 10.1016/j.eururo.2014.08.079
|View full text |Cite
|
Sign up to set email alerts
|

Multifocality and Prostate Cancer Detection by Multiparametric Magnetic Resonance Imaging: Correlation with Whole-mount Histopathology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

14
216
7
7

Year Published

2015
2015
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 381 publications
(244 citation statements)
references
References 30 publications
14
216
7
7
Order By: Relevance
“…However, tumors with a diameter smaller than 1 cm were missed by multiparametric MRI in most cases, even in some cases of high-grade lesions. Lesions with a Gleason score of 6 were missed in 80% of cases regardless of the diameter of the lesions (19).…”
Section: Discussionmentioning
confidence: 99%
“…However, tumors with a diameter smaller than 1 cm were missed by multiparametric MRI in most cases, even in some cases of high-grade lesions. Lesions with a Gleason score of 6 were missed in 80% of cases regardless of the diameter of the lesions (19).…”
Section: Discussionmentioning
confidence: 99%
“…The latter approach has an important limitation as no information is available on regions annotated as normal by the radiologist that could actually harbour PCa. Indeed, in a recent paper Le et al [35] showed that radiologists can miss up to 40% of clinically significant PCas. Conversely, using the whole-mount sections as histologic reference standard provides more accurate label information for training a CAD system [2], as it assesses the ground truth for both PCa extent, grade, and disease infiltration [36].…”
Section: Discussionmentioning
confidence: 99%
“…However, those modalities possess significant limitations (5,6). Conventional imaging has not adequately addressed a variety of important clinical issues, including pretherapy risk stratification, reliable pretherapy staging of patients at risk for pelvic lymph node metastases or systemic disease, and the detection of biochemical recurrence at low PSA levels in patients previously treated for PC with curative intent.…”
mentioning
confidence: 99%